Company / Gross Profit per Share
West Pharmaceutical Services Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$15.27
FY2025
5-year range
$8.19 / $15.27
FY2021-FY2025
Trend
+12.4%
vs FY2024
Sector context
#32 of 99
Health Care
What the data says
At $15.27, West Pharmaceutical Services's gross profit per share ranks #32 of 99 in the Health Care sector. Gross Profit per Share has fluctuated over the past 10 years, ranging from $6.19 in FY2016 to $15.27 in FY2025.
Based on SEC 10-K filings.
15.27 in FY2025 with a 5-year CAGR of +15.7%.
Remained stable around $15.27 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +13.8%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
#32 of 99 in Health CareTop 32% of 99This company $15.27 Sector average $13.82
▼
+10.5% above sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 12.4% year-over-year.
- Ranks #32 out of 99 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.27 | +12.4% |
| FY2024 | $13.59 | -10.9% |
| FY2023 | $15.24 | +47.3% |
| FY2022 | $10.35 | +26.4% |
| FY2021 | $8.19 | +11.2% |
| FY2020 | $7.36 | -10.0% |
| FY2019 | $8.17 | +10.8% |
| FY2018 | $7.38 | +5.2% |
| FY2017 | $7.02 | +13.3% |
| FY2016 | $6.19 | +1.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026